Literature DB >> 7986099

Regulation of two rat liver microsomal carboxylesterase isozymes: species differences, tissue distribution, and the effects of age, sex, and xenobiotic treatment of rats.

E W Morgan1, B Yan, D Greenway, A Parkinson.   

Abstract

The preceding paper described the purification of two rat liver microsomal carboxylesterases, designated hydrolases A and B, that have high affinity (Km approximately 25 microM) and low affinity (Km approximately 400 microM) for para-nitrophenylacetate, respectively. The present study describes the preparation and purification of polyclonal antibodies against these purified enzymes. Each antibody was subjected to immunoabsorption chromatography to remove antibodies against epitopes common to both hydrolases A and B. The resulting isozyme-specific antibodies were used to study the regulation of hydrolases A and B by Western immunoblotting and Ouchterlony immunodiffusion. Liver microsomes from mouse, hamster, rabbit, guinea pig, cat, dog, cynomolgus monkey, and humans contained one or more proteins that were immunochemically related and similar in size (M(r) approximately 60 kDa) to hydrolase A and/or hydrolase B. These proteins were preferentially recognized by the antibody against hydrolase A, except for cat liver microsomal esterase, which was preferentially recognized by antibody against hydrolase B. In rats, the levels of hydrolases A and B in liver microsomes were coregulated as a function of age, sex, and xenobiotic treatment of rats. The levels of both enzymes were very low in 1- and 2-week-old rats, but increased abruptly at 3 weeks of age in both male and female rats. Treatment of mature male rats with 11 known microsomal enzyme inducers caused little (< 35%) or no induction of hydrolase A or B, whereas treatment of rats with beta-naphthoflavone, pregnenolone- 16 alpha-carbonitrile or dexamethasone suppressed the levels of both enzymes. The kinetic analysis of para-nitrophenylacetate hydrolysis described in the preceding paper identified a high-affinity esterase (Km 20-35 microM) in rat liver, testis, lung, prostate, and pancreas and identified a low-affinity enzyme (Km 300-800 microM) in liver, kidney, small intestine, lung, brain, spleen, and heart. Immunoblot analysis established that hydrolase A was present in liver, testis, lung, and prostrate at concentrations that accounted for the high-affinity esterase activity in these tissues. Hydrolase A was not detected in the pancreas, even though this tissue contained low levels of a high-affinity esterase. Hydrolase B was detected in liver and kidney at concentrations that accounted for the low-affinity esterase activity in these tissues. Hydrolase B was not detected in the other tissues examined, some of which (e.g., small intestine) contained high levels of a low-affinity esterase. These results indicate that hydrolases A and B are independently expressed in a wide variety of extrahepatic tissues in rats.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7986099     DOI: 10.1006/abbi.1994.1532

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  13 in total

1.  Ontogenic expression of human carboxylesterase-2 and cytochrome P450 3A4 in liver and duodenum: postnatal surge and organ-dependent regulation.

Authors:  Yi-Tzai Chen; Lynnie Trzoss; Dongfang Yang; Bingfang Yan
Journal:  Toxicology       Date:  2015-02-24       Impact factor: 4.221

2.  Species differences in stereoselective hydrolase activity in intestinal mucosa.

Authors:  Y Yoshigae; T Imai; A Horita; H Matsukane; M Otagiri
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

3.  Isoform-Specific Regulation of Mouse Carboxylesterase Expression and Activity by Prototypical Transcriptional Activators.

Authors:  Angela A Baker; Grace L Guo; Lauren M Aleksunes; Jason R Richardson
Journal:  J Biochem Mol Toxicol       Date:  2015-07-15       Impact factor: 3.642

4.  Transcription factor-mediated regulation of carboxylesterase enzymes in livers of mice.

Authors:  Youcai Zhang; Xingguo Cheng; Lauren Aleksunes; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2012-03-19       Impact factor: 3.922

5.  Dexamethasone regulates differential expression of carboxylesterase 1 and carboxylesterase 2 through activation of nuclear receptors.

Authors:  Chengliang Zhang; Ping Gao; Weifeng Yin; Yanjiao Xu; Daochun Xiang; Dong Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-12-28

6.  Surge in expression of carboxylesterase 1 during the post-neonatal stage enables a rapid gain of the capacity to activate the anti-influenza prodrug oseltamivir.

Authors:  Deshi Shi; Dongfang Yang; Eric P Prinssen; Brian E Davies; Bingfang Yan
Journal:  J Infect Dis       Date:  2011-04-01       Impact factor: 5.226

7.  Age-related inducibility of carboxylesterases by the antiepileptic agent phenobarbital and implications in drug metabolism and lipid accumulation.

Authors:  Da Xiao; Yi-Tzai Chen; Dongfang Yang; Bingfang Yan
Journal:  Biochem Pharmacol       Date:  2012-04-10       Impact factor: 5.858

8.  Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin.

Authors:  Dongfang Yang; Robin E Pearce; Xiliang Wang; Roger Gaedigk; Yu-Jui Yvonne Wan; Bingfang Yan
Journal:  Biochem Pharmacol       Date:  2008-10-15       Impact factor: 5.858

9.  Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone.

Authors:  Vernon W Dolinsky; Donna N Douglas; Richard Lehner; Dennis E Vance
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

10.  Dexamethasone suppresses the expression of multiple rat carboxylesterases through transcriptional repression: evidence for an involvement of the glucocorticoid receptor.

Authors:  Deshi Shi; Jian Yang; Dongfang Yang; Bingfang Yan
Journal:  Toxicology       Date:  2008-09-30       Impact factor: 4.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.